Riskpilot← Back to searchSign inGet full accesssYLVAss Akupunktur AB
ABActiveOrg 5569725632Näsvägen 5Other human health activities n.e.c. · NACE 8699Est. 20140 employees
Revenue 2025
SEK 30K
+150% vs 2024
EBITDA margin
21.8%
+303% vs 2024
Equity ratio
96.4%
Financial strength
Net profit 2025
SEK 5K
+303% vs 2024
| Revenue | SEK 30K | +150% |
| EBITDA | SEK 7K | +303% |
| Net profit | SEK 5K | +303% |
| Total assets | SEK 100K | +7% |
| Equity | SEK 97K | +6% |
| Employees | 0 | — |
Legal name
sYLVAss Akupunktur AB
Org number
5569725632
Legal form
Aktiebolag
NACE code
8699 · Other human health activities n.e.c.
Founded
23 maj 2014
Share capital
SEK 39 970
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-02-28
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Verksamheten ska bedriva kinesisk medicin, massage, Qi-terapi, SPA-behandling, rehabilitering, uthyrning av lokaler samt därmed förenlig verksamhet. Verksamheten kan även bedriva konsultverksamhet inom ekonomiska samt juridiska områden.
Address
Näsvägen 5
Email
ylva.thomander@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 12 | 2 | — | 12 | 30 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −7 | −12 | 0 | 2 | 7 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | −7 | −12 | 0 | 2 | 7 |
| Net financials | — | — | — | — | — |
| Profit before tax | −7 | −12 | 0 | 2 | 7 |
| Tax | −0 | −0 | — | −0 | −1 |
| Net profit | −7 | −12 | — | 1 | 5 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 102 | 88 | — | 94 | 100 |
| Equity | 51 | 39 | — | 91 | 97 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 52 | 50 | — | 2 | 4 |
| Total debt | 52 | 50 | — | 2 | 4 |
EBITDA margin
21.8%
This company
15.8%
Market median
+38% vs market
20212025
Equity ratio
96.4%
This company
38.2%
Market median
+152% vs market
20212025
Return on equity
5.5%
This company
18.4%
Market median
-70% vs market
20212025
Net profit margin
17.3%
This company
8.1%
Market median
+114% vs market
20212025
Asset turnover
0.30×
This company
1.12×
Market median
-73% vs market
20212025
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-03-01 – 2025-02-28
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-03-01 – 2024-02-29
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-03-01 – 2023-02-28
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-03-01 – 2022-02-28
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-03-01 – 2021-02-28
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
JF Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 |
YI Chief Executive Officer | Chief Executive Officer | 2022 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of sYLVAss Akupunktur AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Fredrik Jönsson | Deputy Chief Executive Officer | 0 companies |
| Ylva Inez Liv Thomander | Chief Executive Officer | 0 companies |